Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
This study is ongoing, but not recruiting participants.
Study NCT00600886   Information provided by Novartis

First Received on January 14, 2008.   Last Updated on January 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial